5EYC image
Deposition Date 2015-11-24
Release Date 2016-02-10
Last Version Date 2023-09-27
Entry Detail
PDB ID:
5EYC
Title:
Crystal structure of c-Met in complex with naphthyridinone inhibitor 5
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Hepatocyte growth factor receptor
Gene (Uniprot):MET
Chain IDs:A
Chain Length:309
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.
J.Med.Chem. 59 2328 2342 (2016)
PMID: 26812066 DOI: 10.1021/acs.jmedchem.5b01716

Abstact

Deregulation of the receptor tyrosine kinase mesenchymal epithelial transition factor (MET) has been implicated in several human cancers and is an attractive target for small molecule drug discovery. Herein, we report the discovery of compound 23 (AMG 337), which demonstrates nanomolar inhibition of MET kinase activity, desirable preclinical pharmacokinetics, significant inhibition of MET phosphorylation in mice, and robust tumor growth inhibition in a MET-dependent mouse efficacy model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures